$0.1284
0.00443.55%
Last update: Oct 28, 7:48 PM
aTyr Pharma Inc (ATYR) Stock Price, Quote, News & History
ATYRNASDAQ
aTyr Pharma reached FDA alignment on a Phase 3 study for efzofitimod to treat pulmonary sarcoidosis, beginning in Q4 2026.
You can purchase shares of aTyr Pharma (NASDAQ:ATYR) through any online brokerage.
Other companies in aTyr Pharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
aTyr Pharma has a consensus price target of $60.00.
The stock price for aTyr Pharma (NASDAQ: ATYR) is $0.1296 last updated October 28, 2026 at 7:48 PM EDT.
There are no upcoming dividends for aTyr Pharma.
aTyr Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for aTyr Pharma.
aTyr Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery...
